… oral anticoagulants have recently emerged as an attractive choice for patients requiring
anticoagulation … doses without the need for routine anticoagulation monitoring. They may present …

… To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world …
Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation …

… In clinical trials new oral anticoagulants (NOAC) have proved … The aim of this study was to
evaluate the efficacy and safety … was to evaluate the efficacy and safety of treatment with NOAC …

… Dose-reduced regimens of direct oral anticoagulants (DOACs) may be used for 2 main
purposes: dose-adjusted treatment intended as full-intensity anticoagulation (eg, for stroke …

… oral anticoagulant use in patients with cirrhosis may be as safe as traditional anticoagulants.
… less major bleeding events, while maintaining efficacy at preventing stroke or thrombosis. …

… We found that the novel oral anticoagulants significantly … The novel oral anticoagulants may
potentially address some … and a more predictable anticoagulant effect, thus allowing fixed-…

… Direct oral anticoagulants (DOACs) have emerged as promising alternatives to vitamin K …
We provide an updated overall assessment of the efficacy and safety of those DOACs at …

… CVT has similar efficacy and safety compared to VKAs with better recanalization rate. … safety
and efficacy of DOACs in CVT by pooling studies with or without a standard anticoagulation …

… ,” “warfarin,” “new oral anticoagulant,” “oral factor Xa inhibitor,” and “oral thrombin inhibitor.”
… the safety and efficacy of any new oral anticoagulant compared to oral anticoagulation with …

Aims The well-known limitations of vitamin K antagonists (VKA) led to development of new
oral anticoagulants (NOAC) in non-valvular atrial fibrillation (NVAF). The aim of this meta-…